Trial intelligence / Profile preview

Clindamycin vaginal suppositories for bacterial vaginosis

2011-002386-38Phase 3Terminated

Sponsor
Verisfield
Start
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of clindamycin in bacterial vaginosis (BV), sponsored by Verisfield. Started Aug 2011; status: terminated.

02

Drugs

clindamycin
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on 2011-002386-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002386-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call